lobbying_activities: 2004758
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2004758 | 3e34faec-2a24-4a72-80a1-f615a203b088 | Q2 | THE OB-C GROUP, LLC | 29802 | EMERGENT BIOSOLUTIONS INC. | 2017 | second_quarter | DIS | No specific bill numbers;Matters relating to FY 2017 and FY 2018 Appropriations-provisions related to development, acquisition and stockpiling of medical countermeasures. No specific bill number;Matters related to Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-07-20T11:57:36.593000-04:00 |